Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Figure 3

3A. Photomicrography of a representative set of pre and post-treatment tumor biopsies showing that the malignant component represents almost the half of the tumor. 3B. Methylation analysis of the DAPK gene in the four fragments of the tumor biopsy of an untreated cervical cancer patient. Despite all fragments contained different proportions of malignant cells and stroma the four samples show methylated and unmethylated bands.

Back to article page